Ketogenic diet restrains aging-induced exacerbation of coronavirus infection in mice

  1. Seungjin Ryu
  2. Irina Shchukina
  3. Yun-Hee Youm
  4. Hua Qing
  5. Brandon Hilliard
  6. Tamara Dlugos
  7. Xinbo Zhang
  8. Yuki Yasumoto
  9. Carmen J Booth
  10. Carlos Fernández-Hernando
  11. Yajaira Suárez
  12. Kamal Khanna
  13. Tamas L Horvath
  14. Marcelo O Dietrich
  15. Maxim N Artyomov
  16. Andrew Wang  Is a corresponding author
  17. Vishwa Deep Dixit  Is a corresponding author
  1. Yale University, United States
  2. Washington University School of Medicine, United States
  3. Yale University School of Medicine, United States
  4. New York University Langone Health, United States
  5. Yale School of Medicine, United States

Abstract

Increasing age is the strongest predictor of risk of COVID-19 severity and mortality. Immunometabolic switch from glycolysis to ketolysis protects against inflammatory damage and influenza infection in adults. To investigate how age compromises defense against coronavirus infection, and whether a pro-longevity ketogenic-diet (KD) impacts immune-surveillance, we developed an aging model of natural murine beta coronavirus (mCoV) infection with mouse hepatitis virus strain-A59 (MHV-A59). When inoculated intranasally, mCoV is pneumotropic and recapitulates several clinical hallmarks of COVID-19 infection. Aged mCoV-A59-infected mice have increased mortality and higher systemic inflammation in the heart, adipose tissue and hypothalamus, including neutrophilia and loss of γδ T cells in lungs. Activation of ketogenesis in aged mice expands tissue protective γδ T cells, deactivates the NLRP3 inflammasome and decreases pathogenic monocytes in lungs of infected aged mice. These data establish harnessing of the ketogenic immunometabolic checkpoint as a potential treatment against coronavirus infection in the aged.

Data availability

The single cell RNA-sequencing and bulk RNA-sequencing data has been uploaded to Gene Expression Omnibus (GSE155346 and GSE155347) respectively.

The following data sets were generated

Article and author information

Author details

  1. Seungjin Ryu

    Comparative Medicine and Immunobiology, Yale University, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Irina Shchukina

    Pathology and Immunology, Washington University School of Medicine, St. Louis, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Yun-Hee Youm

    Comparative Medicine and Immunobiology, Yale University, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Hua Qing

    Internal Medicine, Yale University, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Brandon Hilliard

    Internal Medicine, Yale University, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Tamara Dlugos

    Comparative Medicine and Immunobiology, Yale University, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Xinbo Zhang

    Comparative Medicine, Yale University, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Yuki Yasumoto

    Comparative Medicine, Yale University, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Carmen J Booth

    Department of Comparative Medicine, Yale University School of Medicine, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Carlos Fernández-Hernando

    Comparative Medicine and Program in Integrative Cell Signaling and Neurobiology of Metabolism, Yale University, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
  11. Yajaira Suárez

    Comparative Medicine and Program in Integrative Cell Signaling and Neurobiology of Metabolism, Yale University, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
  12. Kamal Khanna

    New York University Langone Health, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  13. Tamas L Horvath

    Program in Integrative Cell Signaling and Neurobiology of Metabolism, Yale University School of Medicine, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7522-4602
  14. Marcelo O Dietrich

    Comparative Medicine, Yale University School of Medicine, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9781-2221
  15. Maxim N Artyomov

    Department of Pathology and Immunology, Washington University School of Medicine, St Louis, United States
    Competing interests
    The authors declare that no competing interests exist.
  16. Andrew Wang

    Yale School of Medicine, New Haven, United States
    For correspondence
    andrew.wang@yale.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6951-8081
  17. Vishwa Deep Dixit

    Comparative Medicine and Immunobiology, Yale University School of Medicine, New Haven, United States
    For correspondence
    vishwa.dixit@yale.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5341-6494

Funding

National Institute on Aging (P01AG051459)

  • Vishwa Deep Dixit

National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR070811)

  • Vishwa Deep Dixit

American Federation for Aging Research (Glenn Foundation for Medical Research Postdoctoral Fellowships in Aging Research)

  • Seungjin Ryu

National Institute of Allergy and Infectious Diseases (1K08AI128745)

  • Andrew Wang

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Chyung-Ru Wang, Northwestern University, United States

Ethics

Animal experimentation: All experiments and animal use were conducted in compliance with the National Institute of Health Guide for the Care and Use of Laboratory Animals and were approved by the Institutional Animal Care and Use Committee (IACUC) protocol (#2019-11572 and 2020-20149) of Yale University.

Version history

  1. Received: January 13, 2021
  2. Accepted: June 15, 2021
  3. Accepted Manuscript published: June 21, 2021 (version 1)
  4. Version of Record published: June 30, 2021 (version 2)

Copyright

© 2021, Ryu et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 7,898
    views
  • 471
    downloads
  • 37
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Seungjin Ryu
  2. Irina Shchukina
  3. Yun-Hee Youm
  4. Hua Qing
  5. Brandon Hilliard
  6. Tamara Dlugos
  7. Xinbo Zhang
  8. Yuki Yasumoto
  9. Carmen J Booth
  10. Carlos Fernández-Hernando
  11. Yajaira Suárez
  12. Kamal Khanna
  13. Tamas L Horvath
  14. Marcelo O Dietrich
  15. Maxim N Artyomov
  16. Andrew Wang
  17. Vishwa Deep Dixit
(2021)
Ketogenic diet restrains aging-induced exacerbation of coronavirus infection in mice
eLife 10:e66522.
https://doi.org/10.7554/eLife.66522

Share this article

https://doi.org/10.7554/eLife.66522

Further reading

    1. Chromosomes and Gene Expression
    2. Immunology and Inflammation
    Rajan M Thomas, Matthew C Pahl ... Andrew D Wells
    Research Article

    Ikaros is a transcriptional factor required for conventional T cell development, differentiation, and anergy. While the related factors Helios and Eos have defined roles in regulatory T cells (Treg), a role for Ikaros has not been established. To determine the function of Ikaros in the Treg lineage, we generated mice with Treg-specific deletion of the Ikaros gene (Ikzf1). We find that Ikaros cooperates with Foxp3 to establish a major portion of the Treg epigenome and transcriptome. Ikaros-deficient Treg exhibit Th1-like gene expression with abnormal production of IL-2, IFNg, TNFa, and factors involved in Wnt and Notch signaling. While Ikzf1-Treg-cko mice do not develop spontaneous autoimmunity, Ikaros-deficient Treg are unable to control conventional T cell-mediated immune pathology in response to TCR and inflammatory stimuli in models of IBD and organ transplantation. These studies establish Ikaros as a core factor required in Treg for tolerance and the control of inflammatory immune responses.

    1. Evolutionary Biology
    2. Immunology and Inflammation
    Mark S Lee, Peter J Tuohy ... Michael S Kuhns
    Research Advance

    CD4+ T cell activation is driven by five-module receptor complexes. The T cell receptor (TCR) is the receptor module that binds composite surfaces of peptide antigens embedded within MHCII molecules (pMHCII). It associates with three signaling modules (CD3γε, CD3δε, and CD3ζζ) to form TCR-CD3 complexes. CD4 is the coreceptor module. It reciprocally associates with TCR-CD3-pMHCII assemblies on the outside of a CD4+ T cells and with the Src kinase, LCK, on the inside. Previously, we reported that the CD4 transmembrane GGXXG and cytoplasmic juxtamembrane (C/F)CV+C motifs found in eutherian (placental mammal) CD4 have constituent residues that evolved under purifying selection (Lee et al., 2022). Expressing mutants of these motifs together in T cell hybridomas increased CD4-LCK association but reduced CD3ζ, ZAP70, and PLCγ1 phosphorylation levels, as well as IL-2 production, in response to agonist pMHCII. Because these mutants preferentially localized CD4-LCK pairs to non-raft membrane fractions, one explanation for our results was that they impaired proximal signaling by sequestering LCK away from TCR-CD3. An alternative hypothesis is that the mutations directly impacted signaling because the motifs normally play an LCK-independent role in signaling. The goal of this study was to discriminate between these possibilities. Using T cell hybridomas, our results indicate that: intracellular CD4-LCK interactions are not necessary for pMHCII-specific signal initiation; the GGXXG and (C/F)CV+C motifs are key determinants of CD4-mediated pMHCII-specific signal amplification; the GGXXG and (C/F)CV+C motifs exert their functions independently of direct CD4-LCK association. These data provide a mechanistic explanation for why residues within these motifs are under purifying selection in jawed vertebrates. The results are also important to consider for biomimetic engineering of synthetic receptors.